Mohindru Mani — SEC Form 4 filings
SEC reporting owner CIK 1664708. 9 Form 4 filings on record with FilingPulse; latest filed 2026-07-16.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-05-17 to 2026-07-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 59,067 shares, $79,890 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 8.
- Largest priced transaction: purchase of 34,364 shares @ $1.46 ($50,000) in Cardiff Oncology, Inc., filed 2026-07-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Cardiff Oncology, Inc. (CRDF) | Chief Executive Officer, Director | 6 | 2 legs · 59,067 sh · $79,890 | — | 5 |
| CytomX Therapeutics, Inc. (CTMX) | Director | 3 | — | — | 3 |
Form 4 filings — Mohindru Mani
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-16 | 4 | Cardiff Oncology, Inc. (CRDF) | Purchase (P): 34,364 @ $1.46 · Purchase (P): 34,364 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | Cardiff Oncology, Inc. (CRDF) | Purchase (P): 24,703 @ $1.21 | EDGAR |
| 2026-06-22 | 4 | CytomX Therapeutics, Inc. (CTMX) | Grant/award (A): 59,000 (derivative) @ $0 | EDGAR |
| 2026-04-02 | 4 | Cardiff Oncology, Inc. (CRDF) | Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2026-02-18 | 4 | Cardiff Oncology, Inc. (CRDF) | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2025-06-30 | 4 | Cardiff Oncology, Inc. (CRDF) | Grant/award (A): 40,565 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | CytomX Therapeutics, Inc. (CTMX) | Grant/award (A): 38,000 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | Cardiff Oncology, Inc. (CRDF) | Grant/award (A): 29,700 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | CytomX Therapeutics, Inc. (CTMX) | Grant/award (A): 38,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1664708 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →